Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Perez

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
Viruses|July 2, 2021
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional EvaluationNatalia Martinez-Acuña, Diana Minerva Avalos-Nolazco, Diana Raquel Rodriguez-Rodriguez, et al.
Cancer Discovery|February 9, 2026
Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomesFernando Perez-Villatoro, Aleksandra Shabanova, Lilian van Wagensveld, et al.
Arthritis Care & Research|May 11, 2021
Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item ReductionSara K Tedeschi, Tristan Pascart, Augustin Latourte, et al.
Arxiv|November 28, 2024
Consensus Statement on Brillouin Light Scattering Microscopy of Biological MaterialsPierre Bouvet, Carlo Bevilacqua, Yogeshwari Ambekar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With GoutNicholas A Sumpter, Riku Takei, Murray Cadzow, et al.
Arthritis Care & Research|September 29, 2015
Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus ExercisesHugh de Lautour, William J Taylor, Ade Adebajo, et al.
Therapeutic Advances in Musculoskeletal Disease|July 18, 2025
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE surveyKaren Schreiber, Christine Graversgaard, Ioannis Parodis, et al.
Annals of the Rheumatic Diseases|June 9, 2026
Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)Georgios Filippou, Laura Pezzoni, Emilio Filippucci, et al.
Annals of the Rheumatic Diseases|July 26, 2023
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition diseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2023
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition DiseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Viruses|July 2, 2021
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional EvaluationNatalia Martinez-Acuña, Diana Minerva Avalos-Nolazco, Diana Raquel Rodriguez-Rodriguez, et al.
Cancer Discovery|February 9, 2026
Single-cell spatial atlas of high-grade serous ovarian cancer uncovers MHC class II as a key predictor of spatial tumor ecosystems and clinical outcomesFernando Perez-Villatoro, Aleksandra Shabanova, Lilian van Wagensveld, et al.
Arthritis Care & Research|May 11, 2021
Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item ReductionSara K Tedeschi, Tristan Pascart, Augustin Latourte, et al.
Arxiv|November 28, 2024
Consensus Statement on Brillouin Light Scattering Microscopy of Biological MaterialsPierre Bouvet, Carlo Bevilacqua, Yogeshwari Ambekar, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2022
Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With GoutNicholas A Sumpter, Riku Takei, Murray Cadzow, et al.
Arthritis Care & Research|September 29, 2015
Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus ExercisesHugh de Lautour, William J Taylor, Ade Adebajo, et al.
Therapeutic Advances in Musculoskeletal Disease|July 18, 2025
Impact of conflicting information on the use of antirheumatic drugs in pregnancy and breastfeeding: perspectives of healthcare providers from the global PRAISE surveyKaren Schreiber, Christine Graversgaard, Ioannis Parodis, et al.
Annals of the Rheumatic Diseases|June 9, 2026
Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD)Georgios Filippou, Laura Pezzoni, Emilio Filippucci, et al.
Annals of the Rheumatic Diseases|July 26, 2023
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition diseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 26, 2023
The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition DiseaseAbhishek Abhishek, Sara K Tedeschi, Tristan Pascart, et al.
Pageof 26